Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of a Telerehabilitation-Supported Exercise Program on Pain, Functional Status, and Quality of Life in Women With Lipedema: A Single-Blind Prospective Randomized Controlled Trial

NCT07885241 is registered in ClinicalTrials.gov with Istanbul University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07885241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of a Telerehabilitation-Supported Exercise Program on Pain, Functional Status, and Quality of Life in Women With Lipedema: A Single-Blind Prospective Randomized Controlled Trial
Lead sponsor
Istanbul University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 19, 2026
Completion date
July 31, 2027
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 2 arms.

  • Telerehabilitation-Supported Exercise Group ExperimentalTelerehabilitation-Supported Exercise

    Participants in this group will receive a telerehabilitation-supported exercise program delivered synchronously via Zoom three times per week for 12 weeks. The program includes warm-up, strengthening, and cool-down exercises. Participants will also receive education about lipedema and written exercise materials

  • Home Exercise Group Active comparatorHome Exercise Program

    Participants in this group will perform a similar home-based exercise program independently three times per week for 12 weeks. They will receive education about lipedema, written exercise materials, and an exercise monitoring form

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Pain Intensity Assessed by Visual Analog Scale (VAS) Baseline, week 12, week 24

    Pain severity in the affected extremities will be assessed using a 10-cm Visual Analog Scale. The scale ranges from "no pain" to "the most severe pain imaginable." Participants will be asked to mark the point on the line that best represents the severity of their pain. The distance from the beginning of the scale to the marked point will be measured and recorded as the pain score. Higher scores indicate greater pain severity.

Lead sponsor's other trials

Istanbul University, most recent start first.

Similar trials

Same condition (Lipedema) and phase, most recent start first.